US FDA approves Ionis Pharma's therapy to treat rare genetic disorder
IONS•FDA approves Ionis therapy for rare genetic disorder
Sept. 3 (Reuters) - The U.S. Food and Drug Administration on Thursday approved Ionis Pharmaceuticals' IONS.O therapy to treat a rare condition that affects the brain's white matter.
